Clinical trial
Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease: VERNE Study
NCT02861118 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease: VERNE Study
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 26, 2016
- Completion date
- April 4, 2018
- Enrollment
- 310 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel disease